YUMAB and ISAR Bioscience aim to overcome the blood-brain barrier

YUMAB GmbH and ISAR Bioscience GmbH announced their collaboration to develop a novel transferrin receptor (TfR) specific antibody for the delivery of biotherapeutics across the blood brain barrier (BBB).  The collaboration combines the complementary expertise and technologies of both companies. ISAR...